INFUSYSTEM HOLDINGS, INC

INFU ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009
Revenue $47.2M $39.0M
Cost of Revenue $7.7M $6.2M
Gross Profit $33.5M $28.6M
Gross Margin 71.0% 73.5%
Operating Expenses
Research & Development
SG&A Expense $20.6M $12.2M
Operating Income $-938.0K $5.3M
Operating Margin -2.0% 13.7%
Interest Expense $3.4M $3.5M
Pretax Income $-3.2M $1.8M
Income Tax Expense $-1.4M $977.0K
Net Income $-1.9M $774.0K
Net Margin -3.9% 2.0%
EPS (Basic) $-0.09 $0.04
EPS (Diluted) $-0.09 $0.04
Shares Outstanding (Basic) 19.7M 18.6M
Shares Outstanding (Diluted) 19.7M 18.9M
Dividends Per Share
← Newer Page 3 of 3 Older →